Otsuka Medical Devices Co., Ltd.
October 29, 2021

Otsuka Medical Devices to Transfer Spine and Trauma Businesses of KiSCO
Through Absorption-Type Split
By Concluding Agreement with Teijin Nakashima Medical
Otsuka Medical Devices Co., Ltd., a wholly-owned subsidiary of Otsuka Holdings Co., Ltd.,announced today that it has signed an agreement with Teijin Nakashima Medical Co., Ltd. to transfer
the spine and trauma (fracture) businesses of its subsidiary, KiSCO Co., Ltd., through an absorptiontype split.
Otsuka Medical Devices plans to complete the transfer of human resources and products from KiSCO’sspine and trauma businesses and theoperations shall start under the new organization on the 1st day ofFebruary 2022.
Background and Timeline Otsuka Medical Devices acquired KiSCO in October 2011 in order to enter the orthopedics
area. KiSCO has been contributing to human health by developing, introducing and marketing
innovative products in the spine and trauma fields.
Otsuka Medical Devices is currently focusing on research and development in the fields ofrenal and endovascular therapies and apheresis,* aiming to provide new treatment options
using cutting-edge medical devices.

As the Teijin Group’s manufacturer of implantable medical devices for orthopedics, Teijin
Nakashima Medical has a strong affinity with KiSCO’s business. Recognizing that Teijin
Nakashima Medical had the foundation to accelerate the growth of KiSCO’s business, Otsuka
Medical Devices agreed to the transfer it through an absorption-type split.

Company Profiles
KiSCO Co., Ltd.
Name
Head office

KiSCO Co., Ltd.
5-3-6 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo Prefecture,Japan

Established

September 14, 1968

Capital1,932,060,000 yen

Representative

Ayumu Nakaji, President and Representative Director

Number of employees

91 (as of April 1, 2021)

Description of business

Development, import, manufacture and sale of medical devices

Websitehttps://www.kisco.jp/en/Teijin Nakashima Medical Co., Ltd.
Name
Head office

Teijin Nakashima Medical Co., Ltd.
688-1 Joto-Kitagata, Higashi-ku, Okayama, Okayama Prefecture,Japan

Established
CapitalRepresentative
Number of employees
Description of business
WebsiteSeptember 3, 2008
100 million yen
Katsuhiko Yokota, President
288 (As of October 16, 2021)
Development, manufacturing, and distribution of medical devices,such as artificial joints, trauma devices, and spinal devices
https://www.teijin-nakashima.co.jp/en/

Otsuka Medical Devices Co., Ltd.
Otsuka Medical Devices Co., Ltd.
Name
2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, Japan
Head officeFebruary 15, 2011
Established7.55 billion yen
CapitalNoriko Tojo, President and Representative Director
Representative
Number of employees
Description of business

Website89 (As of June 30, 2021)
Overseeing medical device operations within the Otsuka Group andthe business activities of companies engaged in related businesses,
as well as all operations incidental to the foregoing activities.
https://www.omd.otsuka.com/en/

Reference* Apheresis: A minimally invasive treatment method that separates plasma and cellular constituents in theblood via extracorporeal therapy techniques. The process also separates and removes harmful fluidfactors, such as antibodies, inflammatory cytokines, metabolites, and toxic substances.

Media contact:
OMD-PR@otsuka.jp